US Threatens to Upend Delta-Aeromexico Deal Over Mexican Actions

The US government is threatening to revoke antitrust immunity for the Delta Air Lines and Grupo Aeromexico joint venture, asserting it no longer serves the public interest and demanding Mexico address anticompetitive behavior. This action includes new US requirements for Mexican airlines to file schedules and seek approval for large charter flights, potentially disrupting the airlines' pricing agreement and impacting cross-border aviation.

Analysis

The U.S. government is threatening to revoke the critical antitrust immunity for the Delta Air Lines (DAL) and Grupo Aeromexico (GRPAA) joint venture, a move that introduces significant regulatory and operational risk for both carriers. According to an order from the U.S. Transportation Department, this action is being considered because the partnership, in the view of U.S. authorities, no longer 'serves the public interest' due to perceived anticompetitive actions by Mexico. The threat is substantiated by immediate new requirements for Mexican airlines to file schedules and seek U.S. approval for large charter flights. The potential withdrawal of antitrust immunity would fundamentally undermine the joint venture's ability to coordinate on pricing and schedules for cross-border routes, jeopardizing the strategic and financial synergies that form the basis of the alliance. This development is reflected in the strongly negative sentiment scores (-0.7 for both DAL and GRPAA), signaling that the market views this as a material threat to the airlines' lucrative trans-border operations.

Key Decisions for Investors

• Investors in both Delta and Aeromexico should immediately re-evaluate position risk, as the potential loss of antitrust immunity would materially impair revenue and profit synergies from the joint venture.
• Monitor developments in U.S.-Mexico regulatory and trade relations closely, as the resolution of this 'show cause' order will be the primary catalyst for share price performance in the near term.
• Consider the potential for increased share price volatility and downward pressure on both DAL and GRPAA until there is clarity on the status of the joint venture's antitrust immunity.
• Assess the precedent this action may set for other international airline joint ventures, as it indicates a willingness by U.S. regulators to use antitrust approvals as leverage in broader trade and policy disputes.